The Controversy Surrounding Ozempic for Weight Loss

The author, who has experienced medical fat-phobia, refused her endocrinologist's prescription of Ozempic, an injectable semaglutide intended to treat type 2 diabetes but increasingly used for rapid weight loss. Ozempic is only approved by Health Canada for the treatment of type 2 diabetes, not for weight loss, and has negative side effects such as nausea, diarrhea, and vomiting. The drug is often not covered by insurance plans when used off-label for weight loss, and costs can vary between $250 and $500 a month. The author refuses to participate in the diet game and won't take Ozempic despite society's pressure to do so.